Crossmark

Re-evaluation of the prognosis of patients with IgA nephropathy and mild proteinuria: a longitudinal study with unexpected results

Published Online: 2026-06-29

Authors

Ma, Xiuhua

Zhang, Sen

Chen, Wenhui

Zhou, Xiaoling https://orcid.org/0000-0001-9626-557X
Funding

Funding for this research was provided by:

Ningxia Key Technology Achievements Transfer and Transformation Project (2025CJE09012)

Ningxia Key Research and Development Program for Special Projects (2023BEG02022)
License Information

Text and Data Mining valid from 2026-06-29

Version of Record valid from 2026-06-29
More Information

Article History

Received: 29 March 2026

Revised: 29 March 2026

Accepted: 12 June 2026

First Online: 29 June 2026

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki guidelines and approved by institutional review board of General Hospital of Ningxia Medical University. The ethical approval number is KYLL-2025-0105 and the decision date is January 24, 2025. Written informed consent was obtained from all patients.

: The authors declare no competing interests.

: The authors acknowledge that the data collection and preliminary analysis were conducted at the General Hospital of Ningxia Medical University. The final drafting, critical revision, and polishing of the manuscript were completed at the People’s Hospital of Ningxia Hui Autonomous Region. We thank both institutions for their support and resources.

Document is current